PRP4K and cancer: Previously, it has been reported that PRP4 is involved in reversing anticancer drug-induced cell death in human cancer cell lines through actin cytoskeleton rearrangement and epithelial–mesenchymal transition (EMT) (Islam et al. 2017; Islam, Ahmed, et al. 2018).